CD86 and myeloid sarcoma: The strong up-regulation in patients’ jugular wall transcriptome of CD86, a costimulatory protein involved in several mechanisms of immune response (Jeannin et al. 1999), could be related to immune activation at the level of jugular wall, potentially including immune cells adhering to the vessel surface, coherently with the well-known autoimmune features of MS.